Menu
Search
|

Menu

Close
X

Surmodics Inc SRDX.OQ (NASDAQ Stock Exchange Global Select Market)

27.15 USD
+0.05 (+0.18%)
As of Feb 23
chart
Previous Close 27.10
Open 27.35
Volume 4,632
3m Avg Volume 12,149
Today’s High 27.35
Today’s Low 27.00
52 Week High 34.15
52 Week Low 22.50
Shares Outstanding (mil) 13.11
Market Capitalization (mil) 417.55
Forward P/E 68.97
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.50 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY18
17
FY17
73
FY16
71
FY15
62
EPS (USD)
FY18
-0.027
FY17
0.292
FY16
0.759
FY15
0.903
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
68.97
32.90
Price to Sales (TTM)
vs sector
5.86
5.77
Price to Book (MRQ)
vs sector
3.82
5.41
Price to Cash Flow (TTM)
vs sector
36.80
23.42
Total Debt to Equity (MRQ)
vs sector
0.00
16.52
LT Debt to Equity (MRQ)
vs sector
0.00
12.22
Return on Investment (TTM)
vs sector
5.07
14.43
Return on Equity (TTM)
vs sector
5.82
16.13

EXECUTIVE LEADERSHIP

Susan Knight
Independent Chairman of the Board, Since 2015
Salary: --
Bonus: --
Gary Maharaj
President, Chief Executive Officer, Director, Since 2010
Salary: $525,675.00
Bonus: --
Andrew LaFrence
Chief Financial Officer , Vice President - Finance and Information Systems, Since 2016
Salary: $283,650.00
Bonus: --
Thomas Greaney
Chief Operating Officer - Medical Devices, Since 2017
Salary: $289,108.00
Bonus: --
Bryan Phillips
Senior Vice President - Legal and Human Resources, General Counsel & Secretary, Since 2011
Salary: $326,600.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

9924 W 74th St
EDEN PRAIRIE   MN   55344-3523

Phone: +1952.5007000

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

SPONSORED STORIES